🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10453
Start Date
2013-01
Trial ID
NCT01772368
Treatments Being Tested
This study is to evaluate the safety and efficacy of fluticasone propionate...
Status
Completed
Location
Teva Investigational Site 13881
Start Date
2016-12-28
Trial ID
NCT02980133
Treatments Being Tested
The primary objective of this study was to evaluate the efficacy of flutica...
Status
Completed
Location
Teva Investigational Site 12429
Start Date
2014-06
Trial ID
NCT02141854
Treatments Being Tested
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10504
Start Date
2012-04
Trial ID
NCT01576718
Treatments Being Tested
The primary objective of this study was to evaluate the efficacy of flutica...
Status
Completed
Location
Teva Investigational Site 12397
Start Date
2014-06
Trial ID
NCT02139644
Treatments Being Tested
The primary objective of the study is to evaluate the long-term safety of f...
Status
Completed
Location
Teva Investigational Site 12068
Start Date
2014-07
Trial ID
NCT02175771
Treatments Being Tested
Each patient will participate in the study for approximately 7 weeks. Parti...
Status
Completed
Location
Teva Investigational Site 13178
Start Date
2015-05
Trial ID
NCT02437604
Treatments Being Tested
The purpose of the study is to characterize the pharmacokinetic profiles of...
Status
Completed
Location
Teva Investigational Site 13679
Start Date
2016-04
Trial ID
NCT02680561
This is a randomized, double-blind, placebo- and open-label active controll...
Status
Completed
Location
Teva Investigational Site 10165
Start Date
2012-01
Trial ID
NCT01479621
Treatments Being Tested
The primary objectives of this study are: * To determine the pharmacokinet...
Status
Completed
Location
Teva Investigational Site 12010
Start Date
2024-05-16
Trial ID
NCT06290102